Review
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 7, 2015; 21(17): 5220-5230
Published online May 7, 2015. doi: 10.3748/wjg.v21.i17.5220
Figure 1
Figure 1 H19 regulating network in gastric cancer. (1): Inhibitory effects; (2): H19 is treated as the precursor of miR-675; (3): H19 positively regulates its binding protein ISM1; (4): Promoting effects; (5): H19 regulates CALN1 indirectly by miR-675.
Figure 2
Figure 2 Hox transcript antisense intergenic RNA regulates gastric cancer metastasis and cell apoptosis by human epithelial growth factor receptor 2 and SUZ12 (A), and hox transcript antisense intergenic RNA acts as a ceRNA (B). (1): miR-331-3p negatively regulates HER2 by binding to its 3’-UTR; (2): HOTAIR indirectly regulates HER2 by competitive binding to miR-331-3p.
Figure 3
Figure 3 Highly upregulated in liver cancer regulatory roles in gastric cancer. (1): Promoting effects. HULC: Highly upregulated in liver cancer.
Figure 4
Figure 4 ANRIL forms a positive feedback loop with miR-449a and E2F1, and functions in gastric cancer. (1): Inhibiting effects; (2): Promoting effects.
Figure 5
Figure 5 Maternally expressed gene 3 regulatory roles in gastric cancer. (1) Promoting effects; (2) Inhibiting effects.
Figure 6
Figure 6 FENDRR regulatory roles in gastric cancer. (1): Inhibiting effects.